首页> 外文期刊>Behavioural pharmacology >Interaction of N-methyl-D-aspartate and group 5 metabotropic glutamate receptors on behavioral flexibility using a novel operant set-shift paradigm.
【24h】

Interaction of N-methyl-D-aspartate and group 5 metabotropic glutamate receptors on behavioral flexibility using a novel operant set-shift paradigm.

机译:N-甲基-D-天门冬氨酸和第5组代谢型谷氨酸受体在行为灵活性上的相互作用,采用了一种新颖的操作设定位移范式。

获取原文
获取原文并翻译 | 示例
       

摘要

Behavioral flexibility or 'set-shifting' refers to the ability to modify ongoing behavior in response to changing goals or environmental contingencies. Impaired behavioral flexibility is associated with disorders such as schizophrenia and addiction. Hypofunction of N-methyl-D-aspartate (NMDA) receptors has been implicated in these impairments. Metabotropic glutamate 5 (mGlu5) receptors closely interact with NMDA receptors and may provide a feasible pharmacological target for indirect manipulation of NMDA receptor function in disease states. The aim of this study was to examine the impact of NMDA and mGlu5 receptors on set-shifting ability. We developed a computer-controlled, operant-based set-shifting task that requires rats to learn sequential discrimination rules based on two distinct perceptual dimensions. Using this task, we found that administration of the NMDA receptor antagonist MK801, both systemically and intracortically, significantly impaired task performance, whereas stimulation or inhibition of mGlu5 receptors did not impair task performance. However, when administered after MK801, potentiation of mGlu5 receptor function reduced the performance impairments observed with MK801 alone. These results suggest an interaction between NMDA and mGlu5 receptors in cognitive flexibility and may provide a novel therapeutic approach for treating disorders associated with aberrant NMDA function.
机译:行为灵活性或“转变”是指能够根据不断变化的目标或环境突发事件来修改正在进行的行为的能力。行为灵活性受损与精神分裂症和成瘾等疾病有关。 N-甲基-D-天门冬氨酸(NMDA)受体的功能减退与这些损伤有关。代谢型谷氨酸5(mGlu5)受体与NMDA受体密切相互作用,并可能为疾病状态下NMDA受体功能的间接操纵提供可行的药理学目标。这项研究的目的是检查NMDA和mGlu5受体对移位能力的影响。我们开发了一种计算机控制的,基于操作员的集合移位任务,该任务要求大鼠根据两个不同的感知维度学习顺序的区分规则。使用这项任务,我们发现全身和皮内注射NMDA受体拮抗剂MK801均显着损害了任务的执行,而刺激或抑制mGlu5受体并没有损害任务的执行。但是,当在MK801之后给药时,mGlu5受体功能增强可减少仅使用MK801观察到的性能损害。这些结果表明NMDA和mGlu5受体之间在认知灵活性方面的相互作用,并可能提供一种新颖的治疗方法,用于治疗与异常NMDA功能相关的疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号